Armata Pharmaceuticals, Inc. (ARMP)
7.935
-0.24
(-2.88%)
USD |
NYAM |
Jun 01, 16:00
7.935
0.00 (0.00%)
After-Hours: 19:43
Armata Pharmaceuticals EPS Diluted (Quarterly) : -3.158 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| Anika Therapeutics, Inc. | -0.3737 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
| Imunon, Inc. | -0.8449 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -115.35M |
| Revenue (Quarterly) | 0.789M |
| Total Expenses (Quarterly) | 116.14M |
| Enterprise Value | 668.85M |
| Gross Profit Margin (Quarterly) | 42.08% |
| Profit Margin (Quarterly) | -14.62K% |
| Earnings Yield | -97.84% |
| Normalized Earnings Yield | -41.49 |